Cargando…
Comparing humoral immune response to SARS‐CoV2 vaccines in people with multiple sclerosis and healthy controls: An Austrian prospective multicenter cohort study
BACKGROUND AND PURPOSE: SARS‐CoV2 vaccination is recommended for patients with multiple sclerosis (pwMS), but response may be limited by disease‐modifying‐treatments (DMTs). The aim of this study was to compare the rates of humoral immune response and safety of SARS‐CoV‐2 vaccines in pwMS and health...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305190/ https://www.ncbi.nlm.nih.gov/pubmed/35102646 http://dx.doi.org/10.1111/ene.15265 |